Several of President Joe Biden’s most powerful appointees and advisers have had business relationships with pharmaceutical giants lobbying the administration on COVID-19 and intellectual property issues, according to documents reviewed by The Daily Poster.
Those ties — and Biden’s longtime alliance with pharmaceutical industry interests — could prove particularly relevant as drug companies now try to defang any new waiver of patent rules that might reduce their profits and facilitate the wider distribution of vaccines to COVID-afflicted countries.
Last summer, Biden broke with his own legislative record and pledged to support relaxing those intellectual property rules to distribute a COVID-19 vaccine, saying it “is the only humane thing in the world to do.”
The post Vaccine Waiver Pledge Tests Biden-World’s Pharma Ties appeared first on PopularResistance.Org.
This post was originally published on PopularResistance.Org.
